ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $327,787 | -24.6% | 12,199 | 0.0% | 0.06% | -22.2% |
| Q2 2023 | $435,016 | +12.7% | 12,199 | -19.7% | 0.07% | +5.9% |
| Q1 2023 | $386,055 | -37.4% | 15,199 | 0.0% | 0.07% | -41.9% |
| Q4 2022 | $616,471 | +20.6% | 15,199 | -1.6% | 0.12% | +9.3% |
| Q3 2022 | $511,000 | -6.1% | 15,448 | 0.0% | 0.11% | +0.9% |
| Q2 2022 | $544,000 | -23.5% | 15,448 | -0.0% | 0.11% | -12.4% |
| Q1 2022 | $711,000 | -30.6% | 15,453 | 0.0% | 0.12% | -32.8% |
| Q4 2021 | $1,025,000 | +6.2% | 15,453 | 0.0% | 0.18% | -3.7% |
| Q3 2021 | $965,000 | -24.6% | 15,453 | 0.0% | 0.19% | -25.5% |
| Q2 2021 | $1,280,000 | +27.9% | 15,453 | +2.4% | 0.25% | +15.7% |
| Q1 2021 | $1,001,000 | -13.6% | 15,089 | 0.0% | 0.22% | -19.3% |
| Q4 2020 | $1,158,000 | +78.2% | 15,089 | 0.0% | 0.27% | +52.8% |
| Q3 2020 | $650,000 | -0.3% | 15,089 | 0.0% | 0.18% | -3.8% |
| Q2 2020 | $652,000 | +50.2% | 15,089 | 0.0% | 0.18% | +21.2% |
| Q1 2020 | $434,000 | -54.6% | 15,089 | 0.0% | 0.15% | -43.4% |
| Q4 2019 | $957,000 | +126.2% | 15,089 | +0.6% | 0.27% | +107.0% |
| Q3 2019 | $423,000 | +59.6% | 15,000 | +50.0% | 0.13% | +61.2% |
| Q2 2019 | $265,000 | +44.0% | 10,000 | 0.0% | 0.08% | +40.4% |
| Q1 2019 | $184,000 | +48.4% | 10,000 | 0.0% | 0.06% | +26.7% |
| Q4 2018 | $124,000 | – | 10,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |